|
1
|
Allford SL, Hunt BJ, Rose P and Machin SJ:
Haemostasis and Thrombosis Task Force, British Committee for
Standards in Haematology: Guidelines on the diagnosis and
management of the thrombotic microangiopathic haemolytic anaemias.
Br J Haematol. 120:556–573. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coppo P1, Wolf M, Veyradier A, Bussel A,
Malot S, Millot GA, Daubin C, Bordessoule D, Pène F, Mira JP, et
al: Prognostic value of inhibitory anti-ADAMTS13 antibodies in
adult-acquired thrombotic thrombocytopenic purpura. Br J Haematol.
132:66–74. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rock GA: Management of thrombotic
thrombocytopenic purpura. Br J Haematol. 109:496–507. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
O'Connor NT, O'Shea MJ and Hill LF:
Vincristine for thrombotic thrombocytopenic purpura. Lancet.
340:4901992. View Article : Google Scholar
|
|
5
|
Durand JM, Lefevre P, Kaplanski G, Telle H
and Soubeyrand J: Vincristine for thrombotic thrombocytopenic
purpura. Lancet. 340:977–978. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Durand JM, Lefevre P, Kaplanski G and
Soubeyrand J: Ineffectiveness of high-dose intravenous
gammaglobulin infusion in thrombotic thrombocytopenic purpura. Am J
Hematol. 42:2341993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Udvardy M and Rak K: Cyclophosphamide for
chronic relapsing thrombotic thrombocytopenic purpura. Lancet.
336:1508–1509. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schneppenheim R and Budde U: von
Willebrand factor: The complex molecular genetics of a multidomain
and multifunctional protein. J Thromb Haemost. 9(Suppl 1): 209–215.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Motto DG, Chauhan AK, Zhu G, Homeister J,
Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD and Ginsburg D:
Shigatoxin triggers thrombotic thrombocytopenic purpura in
genetically susceptible ADAMTS13-deficient mice. J Clin Invest.
115:2752–2761. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng XL, Kaufman RM, Goodnough LT and
Sadler JE: Effect of plasma exchange on plasma ADAMTS13
metalloprotease activity, inhibitor level and clinical outcome in
patients with idiopathic and nonidiopathic thrombotic
thrombocytopenic purpura. Blood. 103:4043–4049. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gadisseur A, Hermans C, Berneman Z,
Schroyens W, Deckmyn H and Michiels JJ: Laboratory diagnosis and
molecular classification of von Willebrand disease. Acta Haematol.
121:71–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bandarenko N and Brecher ME: United States
Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP
ASG): Multicenter survey and retrospective analysis of current
efficacy of therapeutic plasma exchange. J Clin Apher. 13:133–141.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao LQ, Jin ZC, Ji MS, Xia CY, Yu ZX, Liu
J, Hu XL and Yan J: Effect of continuous renal replacement therapy
started at different time on patients with multiple organ
dysfunction syndrome. Zhonghua Yi Xue Za Zhi. 91:1663–1667.
2011.(In Chinese). PubMed/NCBI
|
|
14
|
Sadler JE, Moake JL, Miyata T and George
JN: Recent advances in thrombotic thrombocytopenic purpura.
Hematology Am Soc Hematol Educ Program. 2004.407–423. PubMed/NCBI
|
|
15
|
Paton E and Baldwin IC: Plasma exchange in
the intensive care unit: A 10 year retrospective audit. Aust Crit
Care. 27:139–44. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maruyama Y, Yoshida H, Uchino S, Yokoyama
K, Yamamoto H, Takinami M and Hosoya T: Nafamostat mesilate as an
anticoagulant during continuous veno-venous hemodialysis: A
three-year retrospective cohort study. Int J Artif Organs.
34:571–576. 2011. View Article : Google Scholar : PubMed/NCBI
|
